Most Popular Best's Review Articles Include Forever Chemicals Litigation and More
In the past 90 days, Best’s Review readers have been most interested in the following insurance news coverage:
-
“‘Forever Chemicals’ Spur New Lawsuits” examines how the negative health consequences of per- and polyfluoroalkyl substances (PFAS) are leading to new litigation with worst-case scenarios projecting more than
$160 billion in claims. - “Top Global Insurance Brokers – 2024 Edition” highlights the top 20 global brokers ranked by 2023 total revenue.
-
“Mortgages 90 Days Overdue Double, Drawing Investor Concern: AM Best” features an edited version of a recent Best’s Special Report about how
U.S. life/annuity insurers expanded their allocations to mortgage loans in 2023. -
“NAMIC Chief Executive Officer:
Mutuals Strive To Maintain Mission , Identity Amid Economic Challenges” describes how mutuals have tried to maintain strong community connections while they face decisions about rates and potential economic and regulatory pitfalls.
Best’s Review is AM Best’s monthly insurance magazine, covering emerging issues and trends and evaluating their impact on the marketplace. Access to the complete content of Best’s Review is available here.
AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in
Copyright © 2024 by A.M. Best Company, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240930280006/en/
Executive Editor, Best’s Review®
+1 908 882 1771
[email protected]
Source: AM Best
New York Life Presents $100,000 Donation to SCAN Harbor through the Company’s “Strikeout Series” Partnership with the New York Yankees
Millennial Specialty Insurance Unveils New Brand as MSI
Advisor News
- Goldman Sachs, others weigh in on what’s ahead for the market in 2025
- How is consumers’ investing confidence impacting the need for advisors?
- Can a balance of withdrawals and annuities outshine the 4% rule?
- Economy ‘in a sweet spot’ but some concerns ahead
- Trump, Capitol allies likely looking at quick cryptocurrency legislation
More Advisor NewsAnnuity News
Health/Employee Benefits News
- University of Texas Southwestern Researcher Updates Current Data on Hemophilia (Experiences with Emicizumab: A Retrospective Review of Patients on Emicizumab Therapy at the North Texas Hemophilia Treatment Center): Hematologic Diseases and Conditions – Hemophilia
- Research Conducted at University of Utah Has Updated Our Knowledge about CDC and FDA (Public Health Insurance Expansion and Financial Well-being Indicators Directly Evaluated By the Eligible: Evidence From the United States): CDC and FDA
- Study Findings from Brown University Broaden Understanding of COVID-19 (Continuity of Care and Lifestyle Intervention Programs for Spanish-speaking Immigrants Without Health Insurance At a Free Clinic In Rhode Island): Coronavirus – COVID-19
- Accused killer of US insurance CEO pleads not guilty to 'terrorist' murder
- Where is healthcare least accessible in the United States?
More Health/Employee Benefits NewsLife Insurance News